-
L-Threonine in Metabolic Assay Workflows
2026-09-01
L-Threonine is a controllable nutrient variable for cell culture optimization, amino acid biosynthesis studies, and metabolic profiling—not simply a medium ingredient. This workflow connects defined L-Threonine perturbations with alkaline phosphatase readouts and a metal-free carbon-dot assay, while separating validated evidence from practical starting conditions.
-
Baicalin Methyl Ester Protects the Intestinal Barrier
2026-09-01
A 2024 study combined mouse and MODE-K cell models to show that baicalin methyl ester reduces LPS-associated intestinal inflammation and preserves tight-junction proteins. Its key mechanistic contribution was linking P65 interaction with downstream TNF-α, MLCK, and ZO-1 signaling, while also identifying practical in vivo and in vitro study parameters.
-
L-Threonine as a Metabolic Perturbation Tool
2026-08-31
L-Threonine can serve as a controlled nutrient variable for cell culture optimization, metabolic profiling, and nutritional intervention studies. This article shows how to pair its metabolic perturbation with a metal-free alkaline phosphatase assay while avoiding unsupported claims of direct enzyme inhibition.
-
Hyaluronic Acid Sodium Salt in siRNA Nanoparticles
2026-08-31
Hyaluronic acid sodium salt can serve as an extracellular matrix component and a tunable nanoparticle coating for cell-based delivery studies. This article translates a preclinical Pseudomonas aeruginosa lung-injury study into practical formulation, assay-design, troubleshooting, and validation workflows while separating reported findings from proposed starting conditions.
-
Acetylcysteine for ROS/NF-κB Cell Models
2026-08-30
Acetylcysteine provides a practical redox-control arm for senescence, neurodegeneration, hepatic protection, and respiratory disease experiments. This workflow translates a HEI-OC1 ROS/NF-κB study into dose, timing, controls, and troubleshooting decisions for reproducible bench research.
-
ASB3 Targets MAVS to Suppress Antiviral Immunity
2026-08-29
The 2024 Cell Death & Differentiation study identifies ASB3 as an inducible E3 ligase that weakens antiviral innate immunity by directing MAVS toward K48-linked ubiquitination and proteasomal degradation. Its gain-of-function, loss-of-function, biochemical, and animal infection experiments position ASB3–MAVS regulation as a mechanistic checkpoint connecting viral sensing to interferon production and host susceptibility.
-
7ACC2: Monocarboxylate Transporter 1 Inhibitor
2026-08-28
7ACC2 is a nanomolar carboxycoumarin tool for separating lactate transport, pyruvate handling, and radiation response in cancer models. This workflow connects metabolic phenotyping with the immunosuppressive tumor-macrophage biology highlighted in recent research, while clearly distinguishing validated findings from testable extensions.
-
Latrunculin B: From Actin Control to Translation
2026-08-28
Latrunculin B is more than an actin polymerization inhibitor: it is a time-sensitive mechanistic probe for separating cytoskeletal effects from pathway-specific biology. This thought-leadership article interprets evidence from grass carp reovirus entry studies, outlines practical validation strategies, and positions APExBIO Latrunculin B for translational cytoskeletal research.
-
BI 2536 PLK1 Inhibitor Workflows
2026-08-27
BI 2536 enables selective interrogation of PLK1-driven mitotic control, from G2/M arrest and apoptosis assays to checkpoint-complex studies. This guide connects compound handling, time-resolved cell analysis, and tumor xenograft model planning with practical troubleshooting strategies.
-
IGF2BP1–TUBB4B Signaling in Liver Fibrosis
2026-08-27
The reference study identifies an IGF2BP1–TUBB4B–FAK pathway that connects m6A-dependent RNA stabilization with hepatic stellate cell activation. Its integrated sequencing and functional perturbation strategy provides a useful framework for testing methylation-linked mechanisms while distinguishing pathway-specific effects from broader changes in cellular methyl metabolism.
-
Viral RIPK3 Degradation Controls Inflammation
2026-08-26
Liu and colleagues identified a viral inducer of RIPK3 degradation (vIRD) that connects orthopoxvirus immune evasion with SCF ubiquitin machinery and proteasomal control of necroptosis. Their genetic and infection models show that vIRD–RIPK3 interactions can alter viral replication, inflammation, and mortality in a host-dependent manner.
-
Melittin for GPCR Signal Transduction Research
2026-08-26
Melittin is a versatile bioactive peptide for probing Gs/Gi-regulated signaling, apoptosis, and migration in cancer cell models. This workflow translates glioblastoma lipid-signaling findings into practical, carefully controlled assays while emphasizing dose, timing, and pathway-specific validation.
-
Female LUAD Biomarkers: FOXM1–ERα Network
2026-08-25
This preprint combines transcriptomic, survival, immune, ceRNA, and cellular analyses to examine FOXM1 in female lung adenocarcinoma. Its main contribution is a candidate DGCR5–miR-204-5p–FOXM1–ESR1 regulatory framework, while the incomplete validation of the ceRNA chain highlights important limits for mechanistic interpretation.
-
EPZ5676: Selective DOT1L Inhibitor for Leukemia
2026-08-25
EPZ5676 is a potent and selective DOT1L inhibitor that blocks SAM-dependent H3K79 methylation. Its nanomolar cellular activity in MV4-11 cells supports research on MLL-rearranged leukemia treatment, while its research-only status limits clinical interpretation.
-
SAR405: Precision at the Vps34–Autophagy Nexus
2026-08-24
Autophagy is not a simple energy-saving switch. New AMPK–ULK1 findings show that energy stress can restrain autophagy initiation while preserving the machinery for recovery, making direct interrogation of Vps34 especially valuable. This article positions SAR405 as a selective Vps34 inhibitor for mechanistic studies, assay design, and translational cancer research.